SCHEMBL5401280

SCHEMBL5401280

CN(C(=O)c1ccccc1-c1ccccc1C(=O)N(CCC(=O)O)CCc1cccs1)c1ccco1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.43
ADORA2A P29274 2/20 0.41
POLB P06746 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
ALDH1A1 P00352 6/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 2/20 0.39
HPGD P15428 2/20 0.39
USP2 O75604 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 4/20 0.38
MAPT P10636 2/20 0.38
PKM P14618 2/20 0.38
MCOLN3 Q8TDD5 1/20 0.37
RAB9A P51151 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.36
RECQL P46063 1/20 0.36
ADAM17 P78536 1/20 0.36
LTA4H P09960 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5409193 0.86 TSHR (0.43) TSHRPOLBTDP1ALDH1A1USP2
SCHEMBL5392381 0.85 LMNA (0.38) TSHRTDP1ALDH1A1SMN1; SMN2MEN1
SCHEMBL5399274 0.82 KMT2A (0.52) TSHRPOLBTDP1ALDH1A1HPGD
SCHEMBL5399135 0.82 CYP2D6 (0.43) TSHRADORA2APOLBTDP1ALDH1A1
SCHEMBL5401283 0.81 NPSR1 (0.53) TSHRPOLBALDH1A1SMN1; SMN2HTT
SCHEMBL5408408 0.81 TSHR (0.39) TSHRADORA2APOLBTDP1ALDH1A1
SCHEMBL5402208 0.81 SMN1; SMN2 (0.43) TSHRPOLBTDP1ALDH1A1SMN1; SMN2
SCHEMBL5401147 0.80 KMT2A (0.46) TSHRPOLBTDP1ALDH1A1SMN1; SMN2
SCHEMBL5399042 0.80 LPAR1 (0.39) TSHRTDP1SMN1; SMN2MEN1KMT2A
SCHEMBL5414346 0.80 TBXAS1 (0.42) ALDH1A1SMN1; SMN2HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285680-B2 β-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-10-23 US disclosed
US-20050256160-A1 Beta-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2005-11-17 US disclosed
EP-1533294-A1 BETA-ALANINE DERIVATIVE AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256160-A1 Beta-alanine derivatives and the use thereof TGFB1, PML, APOB TSHR 3382/4885ADORA2A 1708/4885POLB 527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.